17th European AIDS Conference (EACS) 6-9 November 2019

Poster presentation:
Influence of HCV co-infection and hepatitis C treatment on risk of chronic kidney disease in HIV positive persons. Presented by Lars Peters on behalf of the EuroSIDA study. POSTER

Oral presentation:
Prevalence and outcomes of pregnancies over a 20 year period: the EuroSIDA study. Presented by Justyna Kowalska on behalf of the EuroSIDA study. PRESENTATION and WEBCAST
 

EuroSIDA 25 years anniversary symposium at EACS 2019

Major achievements in EuroSIDA: Perspective from invited expert. Presented by Alison Rodger. PRESENTATION and WEBCAST
The role of EuroSIDA in HIV, HCV and TB research in Central East and Eastern Europe. Presented by Daria Podlekareva. PRESENTATION and WEBCAST
What HIV observational cohorts have brought to the field. Presented by Bruno Ledergerber. PRESENTATION and WEBCAST
Adapting HIV cohorts to future challenges in HIV research. Presented by Jens Lundgren. PRESENTATION and WEBCAST
 

10th IAS Conference on HIV Science,Mexico City, Mexico, 21-24 July 2019

Poster presentation:
HCV reinfection among HIV/HCV co-infected individuals in Europe. Presented by Sarah Amele on behalf of the EuroSIDA Study Group. PRESENTATION and POSTER

Prevalence and Outcomes for Heavily Treatment-Experienced (HTE) Individuals Living with HIV in a European Cohort. Presented by Alvaro Humberto Diniz Borges on behalf of Annegret Pelchen-Matthews and the EuroSIDA Study Group. POSTER
 

The International Liver Congress, Vienna 10-14 April 2019

Poster presentation:
Influence of HCV coinfection and HCV treatment on risk of diabetes mellitus in HIV infected persons. Presented by Lars Peters on behalf of the EuroSIDA study. POSTER
 

Conference on Retroviruses and Opportunistic Infections (CROI), Seattle 4-7 March 2019

Poster presentation:
Clinical Outcomes in Persons Coinfected with HIV and HCV: Impact of HCV Treatment Presented by Lars Peters on behalf of the EuroSIDA study. PRESENTATION